ECSP982518A - DERIVATIVES OF 5 'DEOXICITIDINE - Google Patents
DERIVATIVES OF 5 'DEOXICITIDINEInfo
- Publication number
- ECSP982518A ECSP982518A ECSP982518A ECSP982518A EC SP982518 A ECSP982518 A EC SP982518A EC SP982518 A ECSP982518 A EC SP982518A EC SP982518 A ECSP982518 A EC SP982518A
- Authority
- EC
- Ecuador
- Prior art keywords
- group
- atom
- substituted
- formula
- aralkyl
- Prior art date
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- -1 -cycloalkyl Chemical group 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Chemical group 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000004962 physiological condition Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Nuevos derivados de 5- desoxicitidina representados por la fórmula (I) (gráfico), en la que R1 es un átomo de hidrógeno o un grupo fácilmente hidrolizable en condiciones fisiológicas; R2 es un átomo de hidrógeno o un grupo -CO-OR4 (en el que R4 es un grupo hidrocarbonado saturado o insaturado, lineal o ramificado, que consiste en uno o quince átomos de carbono, o un grupo de fórmula -(CH2)n -Y (en el que Y es ciclohexilo o fenilo; n es un entero de 0 a 4); R3 es un átomo de hidrógeno, bromo, yodo o ciano, un grupo alquilo C1-4 (que puede estar sustituido con átomo(s) de halógeno, un grupo vinilo o etinilo (que puede estar sustituido con átomo (s) de halógeno, alquilo C1-4, -cicloalquilo, aralquilo, o un anillo aromático que puede tener uno o más heteroátomo (s)), o un grupo aralquilo que puede estar sustituido, para su uso en terapia médica, especialmente en terapia antitumoral.Novel 5-deoxycytidine derivatives represented by formula (I) (graph), wherein R1 is a hydrogen atom or a group easily hydrolyzable under physiological conditions; R2 is a hydrogen atom or a group -CO-OR4 (where R4 is a linear or branched, saturated or unsaturated hydrocarbon group consisting of one or fifteen carbon atoms, or a group of formula - (CH2) n -Y (where Y is cyclohexyl or phenyl; n is an integer from 0 to 4); R3 is a hydrogen, bromine, iodine or cyano atom, a C1-4 alkyl group (which may be substituted with atom (s ) of halogen, a vinyl or ethynyl group (which may be substituted with halogen atom (s), C1-4alkyl, -cycloalkyl, aralkyl, or an aromatic ring which may have one or more heteroatom (s)), or a Aralkyl group which may be substituted, for use in medical therapy, especially in antitumor therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982518 ECSP982518A (en) | 1998-06-01 | 1998-06-01 | DERIVATIVES OF 5 'DEOXICITIDINE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982518 ECSP982518A (en) | 1998-06-01 | 1998-06-01 | DERIVATIVES OF 5 'DEOXICITIDINE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982518A true ECSP982518A (en) | 1999-04-13 |
Family
ID=42043439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982518 ECSP982518A (en) | 1998-06-01 | 1998-06-01 | DERIVATIVES OF 5 'DEOXICITIDINE |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982518A (en) |
-
1998
- 1998-06-01 EC ECSP982518 patent/ECSP982518A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4940436A1 (en) | DERIVATIVES OF 5´-DEOXICITIDINE AND MANUFACTURING PROCESS THEREOF | |
| MX168756B (en) | PROCEDURE FOR PREPARING IMIDAZO (4,5-b) PYRIDINE COMPOUNDS | |
| ATE516321T2 (en) | COMPOSITIONS CONTAINING FLUOROSUBSTITUTED OLEFINS | |
| ATE111882T1 (en) | 2-SUBSTITUTED ALKYL ETHER AND LIQUID CRYSTAL COMPOSITION. | |
| ATE93232T1 (en) | BIS(METHYLENEDIOXY)BIPHENYL COMPOUNDS. | |
| KR900016190A (en) | 2-phenylpyridine | |
| KR900017974A (en) | Liquid Crystal Component Containing Trimethyleneoxy Group | |
| KR860700250A (en) | New amidine compounds | |
| DE3676151D1 (en) | POLYMERS WITH CONJUGATED DOUBLE BINDINGS. | |
| ES2061487T3 (en) | MACROLID COMPOUNDS. | |
| ATE101392T1 (en) | FLUORINE-SUBSTITUTED BENZENE DERIVATIVES. | |
| BR8805623A (en) | COMPOSITION AND ADDITIVE CONCENTRATE | |
| ES2004141A6 (en) | 1,4-Dihydropyridines, processes for their preparation and their use as antithrombotic drugs. | |
| FI870090A0 (en) | LAONGKEDJADE ALKYLRESORCINOLPHOSFITER. | |
| ECSP982518A (en) | DERIVATIVES OF 5 'DEOXICITIDINE | |
| ES2133153T3 (en) | NEW CYCLICAL DEPSIPEPTIDES WITH 18 RING ATOMS, AND THEIR USE FOR THE FIGHT OF ENDOPARASITES. | |
| NO900732D0 (en) | ARYLALKYLAMINFORBINDELSER. | |
| DE3872543D1 (en) | OPTICALLY ACTIVE 2-SUBSTITUTED PROPYL ETHER AND LIQUID CRYSTAL COMPOSITION. | |
| IT1230595B (en) | IMMEDIATE PEROXYCID DERIVATIVES | |
| KR880013901A (en) | Thienopyridine Derivatives and Antiulcers | |
| ES2045282T3 (en) | A PROCEDURE FOR THE PREPARATION OF 4-SUBSTITUTED ANTHRACICLINONE. | |
| ES468360A1 (en) | PROCEDURE FOR THE PREPARATION OF 2- (2 ', 2', 2'-TRIHALOGENETIL) -4-HALOGENCICLOBUTAN-1-ONA. | |
| ATE9892T1 (en) | DIBENZOCYCLOHEPTENYLIDENES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS. | |
| EP0339088A4 (en) | DRIVE FLUID. | |
| KR920006273A (en) | Chlorophenyl Alkoxyalkyl Compound |